Silencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage

EGF-induced expression of Fused Toes Homolog (FTS) facilitates epithelial–mesenchymal transition and promotes cell migration in ME180 cervical cancer cells

(2014) Sridhar Muthusami et al.   CANCER LETTERS

FTS is responsible for radiation-induced nuclear phosphorylation of EGFR and repair of DNA damage in cervical cancer cells

(2014) Sridhar Muthusami et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma

(2013) Lei Ma et al.   FEBS Journal

EGCG suppresses Fused Toes Homolog protein through p53 in cervical cancer cells

(2013) Sridhar Muthusami et al.   MOLECULAR BIOLOGY REPORTS

Threonine 2609 Phosphorylation of the DNA-Dependent Protein Kinase Is a Critical Prerequisite for Epidermal Growth Factor Receptor-Mediated Radiation Resistance

(2012) P. Javvadi et al.   MOLECULAR CANCER RESEARCH

Epidermal growth factor receptor as a biomarker for cervical cancer

(2011) T. Soonthornthum et al.   ANNALS OF ONCOLOGY

EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment

(2011) G. Liccardi et al.   CANCER RESEARCH

Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study

(2011) John Farley et al.   GYNECOLOGIC ONCOLOGY

Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

(2011) Alessandro D. Santin et al.   GYNECOLOGIC ONCOLOGY

Prognostic Cell Biological Markers in Cervical Cancer Patients Primarily Treated With (Chemo)radiation: A Systematic Review

(2011) Maartje G. Noordhuis et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Fused Toes Homolog modulates radiation cytotoxicity in uterine cervical cancer cells

(2011) Arunkumar Anandharaj et al.   MOLECULAR BIOLOGY REPORTS

Cisplatin resistance: Preclinical findings and clinical implications

(2010) Beate Köberle et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

cIAP2 Upregulated by E6 Oncoprotein via Epidermal Growth Factor Receptor/Phosphatidylinositol 3-Kinase/AKT Pathway Confers Resistance to Cisplatin in Human Papillomavirus 16/18-Infected Lung Cancer

(2010) H.-H. Wu et al.   CLINICAL CANCER RESEARCH

A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix

(2010) Russell J. Schilder et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

FTS (fused toes homolog) a novel oncoprotein involved in uterine cervical carcinogenesis and a potential diagnostic marker for cervical cancer

(2010) Senthilkumar Cinghu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Nuclear EGFR as Novel Therapeutic Target

(2010) Klaus Dittmann et al.   STRAHLENTHERAPIE UND ONKOLOGIE

EGFR Inhibitor Enhances Cisplatin Sensitivity of Oral Squamous Cell Carcinoma Cell Lines

(2009) Yukihiro Hiraishi et al.   PATHOLOGY & ONCOLOGY RESEARCH

An FTS/Hook/p107FHIP Complex Interacts with and Promotes Endosomal Clustering by the Homotypic Vacuolar Protein Sorting Complex

(2008) Lai Xu et al.   MOLECULAR BIOLOGY OF THE CELL